Muscle Energy Technique Versus Strain Counterstrain for Upper Trapezius Myofascial Pain Syndrome
NCT ID: NCT05925205
Last Updated: 2023-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
54 participants
INTERVENTIONAL
2023-05-07
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Experimental group 1.
Muscle energy technique combined with the physical therapy program.
A manual therapy technique
Group B
Experimental group 2.
Strain counterstrain technique combined with the physical therapy program
A manual therapy technique
Group C
Experimental group 3.
The physical therapy program
Electrotherapy and exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Muscle energy technique combined with the physical therapy program.
A manual therapy technique
Strain counterstrain technique combined with the physical therapy program
A manual therapy technique
The physical therapy program
Electrotherapy and exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. They have active myofascial trigger points in the upper trapezius muscle bilaterally according to the established criteria for myofascial trigger points examination.
2. They have neck pain less than three months.
Exclusion Criteria
1. Patients with chronic pain syndrome.
2. Patients having myofascial trigger points in other neck muscles.
3. Patients having a history of an injury or surgery or instability or deformity including both; cervical spine and shoulder.
4. Patients diagnosed with a neurological disorder including altered sensation, migraine, cervical spondylosis, radiculopathy, or myelopathy, and tumour.
5. Patients with a systemic disease including rheumatoid arthritis, Reiter's syndrome, diabetes, fibromyalgia syndrome, and severe medical or psychiatric disorders.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mona Mohamed Ibrahim
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bassem El Nahass, PhD
Role: STUDY_DIRECTOR
Professor of Orthopaedic Physical Therapy, Faculty of Physical Therapy, Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Outpatient Clinics, Faculty of Physical Therapy Kafrelsheikh University
Kafr ash Shaykh, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ibrahim Morsi, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T. 2023-2025
Identifier Type: -
Identifier Source: org_study_id